Skip to main content
. Author manuscript; available in PMC: 2016 Aug 29.
Published in final edited form as: J Nucl Med. 2015 Apr 16;56(6):855–861. doi: 10.2967/jnumed.115.156133

TABLE 1.

Patients’ Demographic Data

Patient
no.
Age
(y)
Height
(cm)
Weight
(kg)
Activity
(MBq)
PD PET
indication
PSA
level
(ng/mL)
Gleason
Score
Previous
treatment
PET
findings
1 66.8 170 74 148 09/12 Relapse 6.7 7 RTx B
2 66.3 178 95 124 01/13 Relapse 0.5 8 RPT None
3 69.9 172 81 146 07/14 Staging 101.2 7 Loc, B,
LNs
4 59.1 185 110 133 07/11 Relapse 1.6 8 RPT and
RTx
LNs
5 63.5 177 70 91 07/14 Follow-
up
1.4 8 ADT B, Loc

PD = primary diagnosis; RTx = radiotherapy; B = bone metastasis; RPT = radical prostatectomy; Loc = tumor tissue in the prostate; LN = lymph node metastasis; ADT = androgen-deprivation therapy.